KP Tissue Releases Fourth Quarter and Full Year 2020 Financial Results
KPLP Q4 2020 Business and Financial Highlights • Revenue was $385.0 million in Q4 2020 compared to $348.1 million in Q4 2019, an increase of $36.9 million or 10.6%. • Adjusted EBITDA was $36.2 million in Q4 2020, including $4.5 million of TAD Sherbrooke start-up costs, compared to $46.0 million in Q4 2019, a decrease of 21.3%. • Successful start-up of new TAD Sherbrooke paper machine, project completed on time and on budget. • Announced the $240 million Sherbrooke Expansion Project. • Declared a quarterly dividend of $0.18 per share to be paid on April 15, 2021. KPLP Full Year 2020 Business and Financial Highlights • Revenue was $1,516.0 million in 2020 compared to $1,357.2 million excluding the divested Mexico business in 2019, an increase of $158.8 million or 11.7%. • Adjusted EBITDA was $197.8 million in 2020, up from $145.0 million in 2019, an increase of 36.4%.